Search Results - "Mestier, Louis"
-
1
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Published in Journal of neuroendocrinology (01-12-2023)“…This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary…”
Get full text
Journal Article -
2
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Published in Neuroendocrinology (01-01-2020)“…The combination of capecitabine (CAP) with temozolomide (TEM) chemotherapy in advanced pancreatic neuroendocrine tumors (PanNET) relies on limited evidence. We…”
Get more information
Journal Article -
3
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)
Published in Digestive and liver disease (01-12-2018)“…This document is a summary of the French intergroup guidelines regarding the management of pancreatic adenocarcinoma (PA), updated in July 2018. This…”
Get full text
Journal Article -
4
Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
Published in Therapeutic Advances in Medical Oncology (2022)“…Mortality from pancreatic ductal adenocarcinoma (PDAC) is increasing worldwide and effective new treatments are urgently needed. The current treatment of…”
Get full text
Book Review Journal Article -
5
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is ≥10%?
Published in The oncologist (Dayton, Ohio) (01-04-2021)“…Background Long‐acting somatostatin analogs (SSAs) are the primary first‐line treatment of well‐differentiated advanced gastroenteropancreatic neuroendocrine…”
Get full text
Journal Article -
6
Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study
Published in The journal of clinical endocrinology and metabolism (01-04-2021)“…Abstract Context Although 24-hour urinary 5-hydroxyindolacetic acid (24u5HIAA) is a key biomarker in midgut neuroendocrine tumors (NETs), it may be inaccurate…”
Get full text
Journal Article -
7
FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
Published in Journal of neuroendocrinology (01-01-2023)“…Neuroendocrine tumors (NETs) are highly vascularized neoplasms. While FOLFOX chemotherapy has shown efficacy in patients with advanced NETs, its combination…”
Get full text
Journal Article -
8
18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
Published in The Journal of nuclear medicine (1978) (01-12-2022)“…Our objective was to compare the respective value of 68Ga-DOTATOC and 18F-DOPA PET/CT for initial staging or presurgical work-up of patients with…”
Get full text
Journal Article -
9
Are recist criteria adequate in assessing the response to therapy in metastatic NEN?
Published in Reviews in endocrine & metabolic disorders (01-09-2021)“…Response to therapy criteria, known as RECIST (Response Evaluation Criteria in Solid Tumours), are widely used to evaluate neuroendocrine tumours (NET)…”
Get full text
Journal Article -
10
Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components
Published in Clinical cancer research (01-12-2021)“…Our team previously defined six quantitative transcriptomic components, and a classification in five subtypes by association of these components. In this…”
Get full text
Journal Article -
11
Laparoscopic‐assisted liver transplantation: A realistic perspective
Published in American journal of transplantation (01-12-2022)“…Laparoscopic approach was rarely described in recipients for liver transplantation (LT). We report the feasibility and safety of laparoscopic‐assisted LT…”
Get full text
Journal Article -
12
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses
Published in Neuroendocrinology (01-06-2019)“…Although chemotherapy combining 5-fluorouracil (5FU)-dacarbazine (DTIC) or temozolomide (TEM)-capecitabine (CAP) is extensively used in patients with…”
Get more information
Journal Article -
13
Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional Hernia
Published in Journal of gastrointestinal surgery (01-02-2020)“…Background The use of absorbable meshes during contaminated or infected incisional hernia (IH) repair is associated with high morbidity and recurrence rates…”
Get full text
Journal Article -
14
Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms
Published in Neuroendocrinology (01-07-2021)“…The characteristics, prognostic factors, and management of duodenal neuroendocrine neoplasms (dNEN) are ill-defined, given their rarity. Whether nonsurgical…”
Get more information
Journal Article -
15
Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut‐like profile
Published in The Journal of pathology (01-09-2022)“…Isolated hepatic localizations of neuroendocrine tumors (NETs) are generally considered as metastatic NETs of unknown primary but could correspond to primary…”
Get full text
Journal Article -
16
Unraveling Pancreatic Segmentation
Published in World journal of surgery (01-04-2018)“…Background Limited pancreatic resections are increasingly performed, but the rate of postoperative fistula is higher than after classical resections…”
Get full text
Journal Article -
17
Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine Tumors
Published in The American journal of gastroenterology (01-02-2024)“…When initial resection of rectal neuroendocrine tumors (r-NETs) is not R0, persistence of local residue could lead to disease recurrence. This study aimed to…”
Get full text
Journal Article -
18
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study
Published in International journal of cancer (01-05-2023)“…Pancreatic adenosquamous carcinoma (PASC) account for <5% of pancreatic malignancies. The efficacy of modern chemotherapy regimens in patients with advanced…”
Get full text
Journal Article -
19
Carcinoid heart disease in patients with midgut neuroendocrine tumours
Published in Journal of neuroendocrinology (01-04-2023)“…Carcinoid heart disease (CHD) is the main complication of carcinoid syndrome (CS) associated with metastatic small intestine neuroendocrine tumours (NETs). The…”
Get full text
Journal Article -
20
Prognostic impact of bone metastases detected by 18F-DOPA PET in patients with metastatic midgut neuroendocrine tumors
Published in European radiology (01-06-2021)“…Objectives Bone metastases (BM) may influence negatively the prognosis of midgut neuroendocrine tumors (NET). The diagnostic sensitivity of 18 F-DOPA PET for…”
Get full text
Journal Article